Annoucement Distribution agreement Enalees x Noack
Enalees and Noack & Co. GmbH are very pleased to announce the signature of a distribution agreement in Eastern countries
Enalees and Noack have signed a global agreement for the distribution of our point-of-care diagnostic kit for horses, dogs and cats.
With this brand-new collaboration, Enalees will enlarge its veterinary diagnostic market to Eastern European countries (Albania, Austria, Bosnia & Herzegovina, Bulgaria, Croatia, Czech Republic, Macedonia, Montenegro, Poland, Romania, Serbia, Slovakia, Slovenia), as part of its international growth strategy.
Noack & Co. GmbH, will therefore propose the largest range of rapid diagnostic kits available in Europe to veterinary practices and hospital. Indeed, over 50 point-of-care diagnostic kit available to diagnose and monitor the progression of infectious & respiratory disease in companion animal (horses, dogs & cats).
« We are really delighted to work with Noack Group, which is dedicated to supply high-quality and innovative products to the animal market. This mission is fully aligned with Enalees one, and this contract will allow the distribution of Enalees innovative iso-PCR tests in Eastern Europe. We are sure the commitment of Noack will allow them to reach the same success we had in Western Europe.»
says Laurent Thiery | co-founder & President | Enalees.
« We are proud to announce our official partnership with ENALEES. ENALEES develops and produces rapid isothermal PCR diagnostic tests for companion animals which enable veterinary professionals to diagnose infectious diseases – both in their veterinary practices and in the field – without the need to send samples to an external laboratory. ENALEES will be our official partner in Austria, Bulgaria, Croatia, Czech Republic, Poland, Romania, Serbia, Slovakia, Slovenia and some other Eastern European countries. With ENALEES on board we are able to offer a further technique, the LAMP method (Loop-mediated isothermal AMPlification Polymerase Chain Reaction) to our customers. »
says DI Oliver Philipp | CEO | Managing Director | Noack Group
About Noack & CO. GmbH :
Noack is a technical marketing and sales company, which handles and distributes products only from international well known and respected producers with high quality standards and technical competence. Our market area covers Austria and most of the Central European Countries. Approximately 120 employees are taking care about the business in our territory. One of Noack’s activities is directed to supply the animal producing industry with innovative, high quality and cost-effective feed supplements/additives to enable them to produce high quality products economically and contribute to a save food chain.
The health status of the animal population is a major concern for Noack. We therefore offer a large portfolio of Veterinary Diagnostic Kits based on ELISA or PCR techniques to the national control authorities, private laboratories, and farms. Noack is a privately owned company and the strong relation with our long-term suppliers and partners guarantees a strong position within our activities in our markets.
For further information, visit noackgroup.com/
About Barentz :
Barentz is a leading global life science ingredients distributor. The company sources branded specialty ingredients from leading manufacturers worldwide and its ingredient experts provide value-added technical support which includes premixing, blending, ingredient formulation and ingredient testing from its state-of-the-art, customized formulation centers and application laboratories in EMEA, Americas and Asia-Pacific.
Established in 1953, Barentz has operations in more than 60 countries with a strong presence in EMEA and Asia-Pacific, and a rapidly growing presence in North America and Latin America. With a turnover of €1.4 billion, the company employs around 1,500 people worldwide and serves over 21,000 customers.
For further information, visit barentz.com.
About Enalees :
Enalees develops and produces rapid isothermal PCR diagnostic tests which enable veterinary professionals to diagnose infectious diseases – both in their veterinary practices and in the field – without the need to send samples to an external laboratory. Its team, which is primarily made up of doctors, engineers and biology technicians, has a particular focus on the development of innovative tests for domesticated animals (horses, dogs and cats).
Based on an isothermal amplification technique, the company’s products can detect 12 infectious diseases in horses, including Lyme disease (or Borreliosis) and equine influenza. To date, 80% of equine veterinary clinics in France use the technology. In 2021, the company also launched ten new tests for diagnosing infectious diseases in dogs and cats, making it the French market leader in veterinary LAMP PCR (Loop-mediated isothermal AMPlification Polymerase Chain Reaction). Enalees’ tests are currently available in Europe and will soon be launched in the US.
Founded in 2015, Enalees moved to the Genopole research center (France) in 2016, where it later set up its own lyophilization platform. This new facility enabled the company to increase its production capacity to over one million tests a year, including products for its own animal health business as well as custom tests for its partners.
Enalees now employs 43 staff. In 2022 it recorded €1.6 million in sales.
For further information, visit enalees.com
Laurent Thiery, PhD
CEO & co-founder
Marketing & Communication Director